Robotic-assisted interval cytoreductive surgery in ovarian cancer: a feasibility study.

Semiramis L Carbajal-MamaniDavid SchweerMerry J MarkhamAshwini K EsnakulaJoseph R GrajoJacqueline C CastagnoJoel Cardenas-Goicoechea

Published in: Obstetrics & gynecology science (2020)

Robotic-assisted interval cytoreductive surgery in ovarian cancer is safe and feasible and may be an alternative to standard laparotomy in selected patients.

Keyphrases

minimally invasive
coronary artery bypass
end stage renal disease
ejection fraction
newly diagnosed
chronic kidney disease
surgical site infection
peritoneal dialysis
prognostic factors
patient reported outcomes
metastatic renal cell carcinoma
acute coronary syndrome
patient reported